Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2025

Feb 4, 2025

29745_dirs_2025-02-04_1a45b2e1-64d6-4541-849c-eccbb1d40527.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-02-01

Reporting Person: Jonsson Patrik (EVP&Pres, CardMetHlth, LLY USA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-01 Common Stock M 3433 Acquired 48016 Direct
2025-02-01 Common Stock F 1535.859 $811.08 Disposed 46480.141 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-01 Restricted Stock Unit $ M 3433 Disposed 2025-02-01 Common Stock (3433) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 574.5 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.